Search results :

Linezolid

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J01XX08

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Diarrhoea 0.8% - 12.1% x x x x x x x x
Upper respiratory tract infection 1% - 5.2% x x x x
Sepsis 0% - 8% x x x x
Nausea 0% - 6.6% x x x x x x x x
Trauma 2% - 4.8% x x x x
Headache 0% - 8.8% x x x x x x x x
Constipation 2.1% - 2.2% x x x x x x
Body temperature increased 0% - 14.1% x x x x x x
Insomnia 1.7% - 2.5% x x x x x x
Vomiting 0.4% - 9.4% x x x x x x x x
Rash 0.4% - 15.2% x x x x x x x x
Cough 0% - 4% x x x x
Hypokalaemia 0% - 3% x x x x x
Loose stools 0% - 3% x x x x x x
Pharyngitis 0.5% - 2.9% x x x x
Dizziness 0.3% - 3% x x x x x x x
Pain localised 0% - 2% x x x x
Abdominal pain generalised 0% - 2.8% x x x x x
Vaginal moniliasis 0.4% - 1.8% x x x x x x x x
Abdominal pain localised 0% - 2.8% x x x x x x x
Dysgeusia 0.2% - 2% x x x x x x x x
Apnoea 0% - 2.3% x x x x
Pneumonia 0% - 2.8% x x x x
Thrombocytosis 0% - 2.8% x x x x
Skin disorder postmarketing, 0% - 2% x x x x x x x
Abdominal pain 0% - 1.6% x x
Dyspnoea 0% - 3.3% x x x x x
Gastrointestinal haemorrhage 0% - 2.3% x x x x x
Generalised oedema 0% - 2.3% x x x x
Liver function test abnormal 0% - 1.6% x x x x x x x x
Oral candidiasis 0% - 4% x x x x x x x x
Eosinophilia 0% - 1.9% x x x x x x x
Pruritus 0% - 2% x x x x x x x x
Fungal infection 0.1% - 1.5% x x x x x x x
Vertigo 0% - 1.2% x x x x x x
Lactic acidosis postmarketing x x x x x x
Anaemia postmarketing, 0% - 7.1% x x x x x x x
Angioedema postmarketing x x x x x x
Hypoglycaemia postmarketing x x x
Leukopenia postmarketing x x x x x x x
Optic nerve disorder postmarketing x x x x x x
Pancytopenia postmarketing x x x x x x x
Neuropathy peripheral postmarketing x x x x x x
Convulsion postmarketing, 0% - 2.8% x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x
Tooth discolouration postmarketing x x x x x
Tongue discolouration postmarketing, 0% - 1.3% x x x x x x x x
Neuropathy postmarketing x
Serotonin syndrome postmarketing x x x x x x
Myelosuppression postmarketing x x x x x x x
Unspecified visual loss postmarketing x x x x x x
Abdominal cramps x
Anaphylactic shock postmarketing, 0% - 10.1% x x x x x x x
Anorexia x
Asthenia x
Candida infection x
Skin candida x
Transient ischaemic attack x
Contusion x
Dermatitis x
Fungal skin infection x
Dyspepsia x x x x x x
Ecchymosis x
Fatigue x
Flatulence x
Gastritis x
Gastrointestinal disorder x x
Glossitis x
Cardiac failure congestive x
Haemorrhage x x x x x x x
Hyperglycaemia x
Hypertension x x x x x x
Hypoaesthesia x
Hyponatraemia x
Jaundice cholestatic x
Cramp muscle x
Neutropenia x
Pancreatitis x
Paraesthesia x
Phlebitis x
Polyuria x
Rectal disorder x
Renal failure x
Skin ulcer x
Stomatitis x
Thrombocytopenia postmarketing, 0% - 4.7% x x x x x x x x
Thrombophlebitis x
Tinnitus x
Erythema x
Urticaria x
Vaginal inflammation x
Dry mouth x
Peripheral vascular disorder x
Chills x
Amylase increased x
Impaired healing x
Lactic dehydrogenase activity increased x
Biliary colic x
Aspartate aminotransferase increased x
Alanine aminotransferase increased x
Decreased appetite x
Disorientation x
Clostridium difficile colitis x
Creatine phosphokinase serum increased x
Increased thirst x
Aplasia x
Vision blurred x
Platelet count decreased x x x x x x x x
Vaginal infection x
Laboratory test abnormal x
Drug interaction x
Sweating increased x
Catheter site phlebitis x
Catheter site pain x
Red man syndrome x x
Somnolence x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

LINEZOLID / ZYVOX

Side effects:22
Source:FDA

LINEZOLID

Side effects:37
Source:FDA Structured Product Label

linezolid / Zyvox

Side effects:48
Source:FDA

linezolid

Side effects:54
Source:FDA Structured Product Label

linezolid

Side effects:54
Source:FDA Structured Product Label

LINEZOLID

Side effects:55
Source:FDA Structured Product Label

LINEZOLID / ZYVOXAM 600 MG

Side effects:98
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label